Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures

Journal of Clinical Microbiology

Volumn 35, Issue 11, 1997, Pages 2791-2794

  Realini, L ^a,b   Van Der Stuyft, P ^b   De Ridder, K ^b   Hirschel, B ^a   Portaels, F ^b  

^a Hôpital Cantonal   (Switzerland)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; AZLOCILLIN; MACROGOL STEARATE; NALIDIXIC ACID; POLYMYXIN B; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; INOCULATION; MYCOBACTERIUM GENAVENSE; NONHUMAN; NUDE MOUSE; PH; PRIORITY JOURNAL; RADIOMETRY;

ANIMALIA; BACILLI; BACTERIA (MICROORGANISMS); MUS MUSCULUS; MYCOBACTERIUM GENAVENSE;

EID: 0030871014     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.11.2791-2794.1997     Document Type: Article

References (20)

1. Bessesen, M. T., J. Shlay, B. Stone-Venohr, D. L. Cohn, and R. R. Reves. 1993. Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS 7:1357-1361.
2. Böttger, E. C., A. Teske, P. Kirschner, S. Bost, H. R. Chang, V. Beer, and B. Hirschel. 1992. Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet 340:76-80.
3. Böttger, E. C., B. Hirschel, and M. B. Coyle. 1993. Mycobacterium genavense sp. nov. Int. J. Syst. Bacteriol. 43:841-843.
4. Böttger, E. C. 1994. Mycobacterium genavense: an emerging pathogen. Eur. J Clin. Microbiol. Infect. Dis. 13:932-936.
5. Camargo, E. E., J. A. Kertcher, S. M. Larson, B. S. Tepper, and H. N. Wagner, Jr. 1982. Radiometrie measurement of differential metabolism of fatty acid by mycobacteria. Intern. J. Lepr. 50:200-204.
6. Conville P.S., J. W. B. Andrews, and F. G. Witebsky. 1995. Effect of PANTA on growth of Mycobacterium kansasii in BACTEC 12B medium. J. Clin. Microbiol. 33:2012-2015.
7. Coyle, M. B., L. C. Carlson, C. K. Wallis, R. B. Leonard, V. A. Raisys, J. O. Kilburn, M. Samadpour, and E. C. Böttger. 1992. Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients. J. Clin. Microbiol. 30:3206-3212.
8. Cutler, R. R., P. Wilson, and F. V. Clarke. 1987. The effect of polyoxyethylene stearate (POES) on the growth of mycobacteria in radiometric 7H12 Middlebrook TB medium. Tubercle 68:209-220.
9. Franzblau, S. G. 1989. Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system. Antimicrob. Agents Chemother. 33:2115-2117.
10. Hirschel, B., H. R. Chang, N. Mach, P. F. Piguet, J. Cox, J. D. Piguet, M. T. Silva, L. Larsson, P. R. Klatser, J. E. R. Thole, L. Rigouts, and F. Portaels. 1990. Fatal infection with a novel, unidentified Mycobacterium in a man with the acquired immunodeficiency syndrome. N. Engl. J. Med. 323:109-113.
11. Jackson, K., A. Sievers, B. C. Ross, and B. Dwyer. 1992. Isolation of a fastidious Mycobacterium species from two AIDS patients. J. Clin. Microbiol. 30:2934-2937.
12. Miller, M. A., L. Thibert, F. Desjardins, S. H. Siddiqi, and A. Dascal. 1996. Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test. J. Clin. Microbiol. 34:84-86.
13. Nolte, F. S., and B. Metchock. 1995. Mycobacterium, p. 400-437. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
14. Pechère, M., M. Opravil, A. Wald, J. P. Chave, M. Bessesen, A. Sievers, R. Hein, J. Vonoverberch, R. A. Clark, E. Tortoli, S. Emler, P. Kirschner, V. Gabriel, E. C. Böttger, and B. Hirschel. 1995. Clinical and epidemiological features of infection with Mycobacterium genavense. Arch. Intern. Med. 155: 400-404.
15. Portaels, F., and S. R. Pattyn. 1982. Growth of mycobacteria in relation to the pH of the medium. Ann. Microbiol. (Institut Pasteur). 133B:213-221.
16. Shafran, S. D., G. D. Taylor, and J. A. Talbot. 1995. Disseminated Mycobacterium genavense infection in Canadian AIDS patients. Tubercle Lung Dis. 76:168-170.
17. Shepard, C. C., and D. H. McRae. 1968. A method for counting acid-fast bacteria. Int. J. Lepr. 36:78-82.
18. Siddiqi, S. H., J. P. Libonati, M. E. Carter, N. M. Hooper, J. F. Baker, C. C. Hwangbo, and L. E. Warfel. 1988. Enhancement of mycobacterial growth in Middlebrook 7H12 medium by polyoxyethylene stearate. Curr. Microhipl. 17:105-110.
19. Siddiqi, S. H., A. Laszlo, W. R. Butler, and J. O. Kilburn. 1993. Bacteriologic investigations of unusual mycobacteria isolated from immunocompromised patients. Diagn. Microbiol. Infect. Dis. 16:321-323.
20. Tortoli, E., M. T. Simonetti, D. Dionisio, and M. Meli. 1994. Cultural studies on two isolates of Mycobacterium genavense from patients with the acquired immunodeficiency syndrome. Diagn. Microbiol. Infect. Dis. 18:7-12.